Trichy Daily

Candidemia Market Size, Share, Trends, Growth, Leading Companies, Emerging Drugs, and Epidemiology Forecast

 Breaking News
  • No posts were found

Candidemia Market Size, Share, Trends, Growth, Leading Companies, Emerging Drugs, and Epidemiology Forecast

March 08
16:48 2021
Candidemia Market Size, Share, Trends, Growth, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Delveinsight Business Research LLP

DelveInsight’s “Candidemia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Candida infection can occur in almost any part of the body. Usually, it develops on mucous membranes (in the mouth, genitals, etc.), however, the infection can also spread into the bloodstream. The presence of Candida species in the blood is known as Candidemia. When this infection spreads from the bloodstream to other parts of the body (such as the eyes, kidney, liver, and brain), it is called Invasive Candidemia. Common symptoms of candidemia include fever and chills that do not improve with antibiotics. The infection can also cause septic shock and therefore may include symptoms such as low blood pressure, fast heart rate, and rapid breathing.

Get FREE sample copy at: 
https://www.delveinsight.com/sample-request/candidemia-market

The Candidemia market report also covers emerging drugs, current treatment practices, Candidemia market share of the individual therapies, current and forecasted Candidemia Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Candidemia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Candidemia Market

Candidemia Market Key Facts

As per Delveinsight, Candidemia is more prevalent in males than in females.

The study titled “National Burden of Candidemia, United States, 2017” by Tsay et al. (2018), suggests that an estimated 23,000 candidemia cases occurred in the United States in 2017. Overall estimated incidence was calculated to be 7.0 per 100,000 persons, with elevated rates in adults ≥65 years (20.3 per 100,000), males (8.0 per 100,000).

Key Benefits of Candidemia Market Report

  • Candidemia market report provides an in-depth analysis of Candidemia Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Candidemia market report will help in developing business strategies by understanding the Candidemia Market trends & developments, key players, and future market competition that will shape and drive the Candidemia market in the upcoming years.

  • The Candidemia market report covers Candidemia current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Candidemia market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Candidemia Market

The Candidemia market size is expected to increase during the forecast period owing to the rise in the number of incident cases during the forecast period.

The Candidemia market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Candidemia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Candidemia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Candidemia Epidemiology

The Candidemia epidemiology section covers insights about the historical and current Candidemia patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Candidemia Drugs Uptake and Key Market Players

The Candidemia Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Candidemia market or expected to get launched in the market during the study period. The analysis covers Candidemia market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The Candidemia market size is anticipated to change in the coming years owing to the improvement in the research and development undertaking. Worldwide, several key players are involved in developing therapies for Candidemia.

Candidemia Companies:
Cidara Therapeutics
Amolyx
Scynexis
And many others.

Candidemia Therapies covered in the report include:
Reezafungin
Fosmanogepix
Ibrexafungerp
And many others.

Table of Content

1. Key Insights

2. Executive Summary 

3. Candidemia Competitive Intelligence Analysis

4. Candidemia Market Overview at a Glance

5. Candidemia Disease Background and Overview

6. Candidemia Patient Journey

7. Candidemia Epidemiology and Patient Population

8. Candidemia Treatment Algorithm, Current Treatment, and Medical Practices

9. Candidemia Unmet Needs

10. Key Endpoints of Candidemia Treatment

11. Candidemia Marketed Products

12. Candidemia Emerging Therapies

13. Candidemia Seven Major Market Analysis

14. Attribute Analysis

15. Candidemia Market Outlook (7 major markets)

16. Candidemia Access and Reimbursement Overview

17. KOL Views on the Candidemia Market.

18. Candidemia Market Drivers

19. Candidemia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Other Latest Reports By Delveinsight – 
Anti-hypertension Market Insight
DelveInsight’ s “Anti-hypertension Market Insights, Epidemiology, and Market Forecast 2030” report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology as well as the Anti-hypertension market size, share, trends, and forecast for the seven major markets (i.e. the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles